The Manila Times

Chiesi Global Rare Diseases Announces FDA Approval of JUXTAPID® (lomitapide) Capsules for Pediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)

Approval expands indication of JUXTAPID® to include children 2 years of age and older with HoFH. This announcement was made ...